• Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
HBOT News Network Logo
  • Home
  • Special Reports
  • News & Research
  • Conversations
  • Research Rundowns
  • International Indications
Veterans Special Report
  • Home
  • Special Reports
  • News & Research
  • Conversations
  • Research Rundowns
  • International Indications

Use of indocyanine green fluorescent angiography in a hyperbaric patient with soft tissue radiation necrosis: a case report.

by HBOT News | Aug 6, 2017 | Cancer

Abstract: Indocyanine green fluorescent angiography (ICFA), commonly used to assess vascularity in patients with non-healing lower extremity wounds, is emerging as a useful adjunct for hyperbaric oxygen (HBO₂)therapy patients. We describe the use of ICFA to measure...

Pain improvement in rheumatoid arthritis with hyperbaric oxygen: report of three cases.

by HBOT News | Aug 2, 2017 | Rheumatoid Arthritis

Abstract: Rheumatoid arthritis (RA) is a chronic, erosive, symmetrical inflammatory disease that can progress to synovial destruction, severe disability and premature mortality. Immunotherapies, while beneficial, can cause significant adverse events. Three patients...

Pain improvement in rheumatoid arthritis with hyperbaric oxygen: report of three cases.

by HBOT News | Aug 2, 2017 | Rheumatoid Arthritis

Abstract: Rheumatoid arthritis (RA) is a chronic, erosive, symmetrical inflammatory disease that can progress to synovial destruction, severe disability and premature mortality. Immunotherapies, while beneficial, can cause significant adverse events. Three patients...

Pain improvement in rheumatoid arthritis with hyperbaric oxygen: report of three cases.

by HBOT News | Aug 2, 2017 | Chronic Wounds

Abstract: Rheumatoid arthritis (RA) is a chronic, erosive, symmetrical inflammatory disease that can progress to synovial destruction, severe disability and premature mortality. Immunotherapies, while beneficial, can cause significant adverse events. Three patients...

Frequency and clinical impact of preoperative circulating tumor cells in resectable non-metastatic lung adenocarcinomas.

by HBOT News | Jul 25, 2017 | Cancer

Abstract: Despite successful surgery, 30-50% of patients with resectable non-small cell lung cancer develop tumor recurrence within 5 years of surgery. In this prospective study, we performed CTC enumerations in 40 patients with non-metastatic lung adenocarcinoma...
« Older Entries
Next Entries »

Recent Posts

  • Treat the Concussion: How HBOT Is Changing the Playbook for Concussions — An Interview with Dr. Daphne Denham
  • Understanding Hyperbaric Chambers: Types, Risks, and Safety Tips for Patients
  • Overcoming the Placebo Challenge: New Trial Confirms HBOT Benefits for TBI and PTSD
  • Concussion Recovery: New Study Supports HBOT for Student Athletes
  • Can Oxygen Make You Younger? What Bryan Johnson’s $2M HBOT Experiment Really Tells Us

Archives

Categories

Hyperbaric Oxygen Therapy is used around the world to extend and improve quality of life by augmenting the treatment of all injuries, diseases and infections, as well as to improve overall wellness. HBOT involves breathing 100% oxygen in a pressurized chamber to increase oxygen levels in blood plasma. A century of clinical research has shown that increased oxygen in plasma accelerates our natural ability to heal through neurogenesis and angiogenesis.
  • Follow
  • Follow
  • Follow
  • Follow
  • Policies
  • Contact

Our Newsletter

Join our mailing list and get notified when we publish news or record new episodes.

Name(Required)

© 2015-2023 HBOT News – Your news source for the latest news and research about hyperbaric oxygen therapy.